Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034401 | 12703440 | 1 | I | 20160818 | 20160831 | 20160831 | EXP | GB-MHRA-ADR 23601167 | GB-TEVA-687344ACC | TEVA | 54.00 | YR | F | Y | 0.00000 | 20160831 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034401 | 12703440 | 1 | PS | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | 400 MILLIGRAM DAILY; ONLY TOOK 4 TABLETS. | N | U | 18679 | 200 | MG | TABLET | BID | |||||
| 127034401 | 12703440 | 2 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | 0 | ||||||||||||
| 127034401 | 12703440 | 3 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127034401 | 12703440 | 1 | Urinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127034401 | 12703440 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127034401 | 12703440 | Headache | |
| 127034401 | 12703440 | Malaise | |
| 127034401 | 12703440 | Pruritus | |
| 127034401 | 12703440 | Swelling face | |
| 127034401 | 12703440 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |